<DOC>
	<DOCNO>NCT02700516</DOCNO>
	<brief_summary>Glomerulonephritis ( GN ) lead cause end-stage renal disease 30 % 50 % patient receive renal transplant . The exact prevalence either recurrent de novo GN unknown since considerable number patient never undergo allograft biopsy , leave GN underdiagnosed . The aim study evaluate effect recurrent GN prevalence , risk factor , clinicopathological feature , outcome renal transplant recipient .</brief_summary>
	<brief_title>Recurrent Glomerulonephritis After Renal Transplantation</brief_title>
	<detailed_description>Glomerulonephritis lead cause end-stage renal disease 30 % 50 % patient receive renal transplant . Even though recurrent de novo posttransplant primary GN third frequent cause renal allograft loss renal transplantation , different recurrence rate report different patient series worldwide . With implementation diverse improve immunosuppressive treatment regimens prolongation graft survival , renal allograft loss cause recurrent de novo GN important ever . Data obtain compare patient recurrent primary GN patient non-recurrent GN renal transplant recipients non-GN etiology shall bring new approach daily practice manage patient GN renal failure , assess transplant candidate apply new therapy .</detailed_description>
	<mesh_term>Glomerulonephritis</mesh_term>
	<criteria>Patients underwent renal transplantation endstage renal disease cause primary glomerulonephritis biopsyproven recurrent primary glomerulonephritis ( Recurrent GN group ) Patients underwent renal transplantation endstage renal disease cause primary glomerulonephritis sign recurrence ( Nonrecurrent GN group ) Patients underwent renal transplantation endstage renal disease link etiology primary glomerulonephritis ( NonGN group ) Patients unwilling unable consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>